mitoxantrone has been researched along with Gestational Trophoblastic Neoplasia in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Gestational Trophoblastic Neoplasia: Gestational Trophoblastic diseases that are malignant. It does not include HYDATIDIFORM MOLE. However, there is a minority of authors that consider the term gestational trophoblastic neoplasia synonymous with gestational trophoblastic disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, NM | 1 |
| Chang, WH | 1 |
| Wang, PH | 2 |
| Cheng, M | 1 |
| Lee, NR | 1 |
| Jareemit, N | 1 |
| Horowitz, NS | 1 |
| Goldstein, DP | 1 |
| Berkowitz, RS | 1 |
| Elias, KM | 1 |
3 other studies available for mitoxantrone and Gestational Trophoblastic Neoplasia
| Article | Year |
|---|---|
The first-line therapy for low-risk gestational trophoblastic neoplasia: Does single agent or multi-agent work?
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gestational Trophoblastic Disease | 2019 |
The use of VMP regimen as the first line chemotherapy for low-risk gestational trophoblastic neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gestational Trophoblastic Disease | 2019 |
EMA vs EMACO in the treatment of gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Doxorubicin; Etopos | 2020 |